Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease

Publisher： Cambridge University Press

E-ISSN： 1741-203x|23|9|1376-1385

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.23, Iss.9, 2011-11, pp. : 1376-1385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trajectories of cognitive decline in Alzheimer's disease

By  

International Psychogeriatrics, Vol. 22, Iss. 2, 2010-03 ,pp. : 281-290

Cambridge University Press

Access to resources Recommend Favorite

Predicting Rate of Cognitive Decline in Probable Alzheimer's Disease

By Rasmusson D.X.   Carson K.A.   Brookmeyer R.   Kawas C.   Brandt J.  

Brain and Cognition, Vol. 31, Iss. 2, 1996-02 ,pp. : 133-147

Academic Press

Access to resources Recommend Favorite

Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up

By  

International Psychogeriatrics, Vol. 24, Iss. 6, 2012-06 ,pp. : 948-958

Cambridge University Press

Access to resources Recommend Favorite

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review

By  

International Psychogeriatrics, Vol. 24, Iss. 5, 2012-05 ,pp. : 689-697

Cambridge University Press

Access to resources Recommend Favorite

The importance of high quality trials of cognitive interventions in Alzheimer's disease

By  

International Psychogeriatrics, Vol. 28, Iss. 5, 2016-04 ,pp. : 705-706

Cambridge University Press

Access to resources Recommend Favorite